Do the patients with peripheral atherosclerosis need to a medical therapy before the revascularization?
In the review article are provided the approaches to the therapy for improvement of prognosis in patients with peripheral and multifocal atherosclerosis which are available now; some limitations and a real situation are designated for the antithrombotic therapy in this category of patients. Accordin...
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2019-12-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/viewFile/33757/pdf |
_version_ | 1818500898394996736 |
---|---|
author | O L Barbarash V V Kashtalap |
author_facet | O L Barbarash V V Kashtalap |
author_sort | O L Barbarash |
collection | DOAJ |
description | In the review article are provided the approaches to the therapy for improvement of prognosis in patients with peripheral and multifocal atherosclerosis which are available now; some limitations and a real situation are designated for the antithrombotic therapy in this category of patients. According to the clinical trial COMPASS the prospects of wide use of a combination of acetylsalicylic acid and a rivaroxsaban of 2.5 mg 2 times a day in the patients with chronic coronary heart disease and/or symptom peripheral atherosclerosis are designated. |
first_indexed | 2024-12-10T20:48:53Z |
format | Article |
id | doaj.art-19afaf35dc8041899983b595fa05f907 |
institution | Directory Open Access Journal |
issn | 0040-3660 2309-5342 |
language | Russian |
last_indexed | 2024-12-10T20:48:53Z |
publishDate | 2019-12-01 |
publisher | "Consilium Medicum" Publishing house |
record_format | Article |
series | Терапевтический архив |
spelling | doaj.art-19afaf35dc8041899983b595fa05f9072022-12-22T01:34:10Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422019-12-01911212913410.26442/00403660.2019.12.00049830485Do the patients with peripheral atherosclerosis need to a medical therapy before the revascularization?O L Barbarash0V V Kashtalap1Research Institute for Complex Issues of Cardiovascular Diseases; Kemerovo State Medical UniversityResearch Institute for Complex Issues of Cardiovascular Diseases; Kemerovo State Medical UniversityIn the review article are provided the approaches to the therapy for improvement of prognosis in patients with peripheral and multifocal atherosclerosis which are available now; some limitations and a real situation are designated for the antithrombotic therapy in this category of patients. According to the clinical trial COMPASS the prospects of wide use of a combination of acetylsalicylic acid and a rivaroxsaban of 2.5 mg 2 times a day in the patients with chronic coronary heart disease and/or symptom peripheral atherosclerosis are designated.https://ter-arkhiv.ru/0040-3660/article/viewFile/33757/pdfperipheral atherosclerosischronic coronary heart diseasemultifocal atherosclerosisprognosisantithrombotic therapyrivaroxaban |
spellingShingle | O L Barbarash V V Kashtalap Do the patients with peripheral atherosclerosis need to a medical therapy before the revascularization? Терапевтический архив peripheral atherosclerosis chronic coronary heart disease multifocal atherosclerosis prognosis antithrombotic therapy rivaroxaban |
title | Do the patients with peripheral atherosclerosis need to a medical therapy before the revascularization? |
title_full | Do the patients with peripheral atherosclerosis need to a medical therapy before the revascularization? |
title_fullStr | Do the patients with peripheral atherosclerosis need to a medical therapy before the revascularization? |
title_full_unstemmed | Do the patients with peripheral atherosclerosis need to a medical therapy before the revascularization? |
title_short | Do the patients with peripheral atherosclerosis need to a medical therapy before the revascularization? |
title_sort | do the patients with peripheral atherosclerosis need to a medical therapy before the revascularization |
topic | peripheral atherosclerosis chronic coronary heart disease multifocal atherosclerosis prognosis antithrombotic therapy rivaroxaban |
url | https://ter-arkhiv.ru/0040-3660/article/viewFile/33757/pdf |
work_keys_str_mv | AT olbarbarash dothepatientswithperipheralatherosclerosisneedtoamedicaltherapybeforetherevascularization AT vvkashtalap dothepatientswithperipheralatherosclerosisneedtoamedicaltherapybeforetherevascularization |